1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Physical Rehabilitation Center Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Physical Rehabilitation Center Market, by Program
8.1.1. Standard Outpatient Programs
8.1.1.1. Market Revenue and Forecast
8.1.2. Intensive Outpatient Programs (IOP)
8.1.2.1. Market Revenue and Forecast
8.1.3. Partial Hospitalisation Programs (PHP)
8.1.3.1. Market Revenue and Forecast
8.1.4. Hybrid Tele-Outpatient Programs
8.1.4.1. Market Revenue and Forecast
8.1.5. Specialised Day Rehabilitation (Neuro, Cardiac, Ortho)
8.1.5.1. Market Revenue and Forecast
9.1. Physical Rehabilitation Center Market, by Therapy
9.1.1. Physical Therapy
9.1.1.1. Market Revenue and Forecast
9.1.2. Occupational Therapy
9.1.2.1. Market Revenue and Forecast
9.1.3. Speech & Language Therapy
9.1.3.1. Market Revenue and Forecast
9.1.4. Cognitive Behavioural Therapy (CBT)
9.1.4.1. Market Revenue and Forecast
9.1.5. Contingency Management (CM)
9.1.5.1. Market Revenue and Forecast
9.1.6. Motivational Interviewing (MI)
9.1.6.1. Market Revenue and Forecast
9.1.7. Virtual-Reality-Assisted Therapy
9.1.7.1. Market Revenue and Forecast
9.1.8. Aquatic / Ocean Therapy
9.1.8.1. Market Revenue and Forecast
10.1. Physical Rehabilitation Center Market, by Condition Treated
10.1.1. Musculoskeletal Rehabilitation
10.1.1.1. Market Revenue and Forecast
10.1.2. Neurological Rehabilitation
10.1.2.1. Market Revenue and Forecast
10.1.3. Cardiac Rehabilitation
10.1.3.1. Market Revenue and Forecast
10.1.4. Pulmonary Rehabilitation
10.1.4.1. Market Revenue and Forecast
10.1.5. Substance-Use-Disorder Rehabilitation
10.1.5.1. Market Revenue and Forecast
11.1. Physical Rehabilitation Center Market, by End User
11.1.1. Paediatric Population
11.1.1.1. Market Revenue and Forecast
11.1.2. Adult Population
11.1.2.1. Market Revenue and Forecast
11.1.3. Geriatric Population
11.1.3.1. Market Revenue and Forecast
11.1.4. Sports-Injury Patients
11.1.4.1. Market Revenue and Forecast
11.1.5. Workers’ Compensation Cases
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Program
12.1.2. Market Revenue and Forecast, by Therapy
12.1.3. Market Revenue and Forecast, by Condition Treated
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Program
12.1.5.2. Market Revenue and Forecast, by Therapy
12.1.5.3. Market Revenue and Forecast, by Condition Treated
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Program
12.1.6.2. Market Revenue and Forecast, by Therapy
12.1.6.3. Market Revenue and Forecast, by Condition Treated
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Program
12.2.2. Market Revenue and Forecast, by Therapy
12.2.3. Market Revenue and Forecast, by Condition Treated
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Program
12.2.5.2. Market Revenue and Forecast, by Therapy
12.2.5.3. Market Revenue and Forecast, by Condition Treated
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Program
12.2.6.2. Market Revenue and Forecast, by Therapy
12.2.6.3. Market Revenue and Forecast, by Condition Treated
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Program
12.2.7.2. Market Revenue and Forecast, by Therapy
12.2.7.3. Market Revenue and Forecast, by Condition Treated
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Program
12.2.8.2. Market Revenue and Forecast, by Therapy
12.2.8.3. Market Revenue and Forecast, by Condition Treated
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Program
12.3.2. Market Revenue and Forecast, by Therapy
12.3.3. Market Revenue and Forecast, by Condition Treated
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Program
12.3.5.2. Market Revenue and Forecast, by Therapy
12.3.5.3. Market Revenue and Forecast, by Condition Treated
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Program
12.3.6.2. Market Revenue and Forecast, by Therapy
12.3.6.3. Market Revenue and Forecast, by Condition Treated
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Program
12.3.7.2. Market Revenue and Forecast, by Therapy
12.3.7.3. Market Revenue and Forecast, by Condition Treated
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Program
12.3.8.2. Market Revenue and Forecast, by Therapy
12.3.8.3. Market Revenue and Forecast, by Condition Treated
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Program
12.4.2. Market Revenue and Forecast, by Therapy
12.4.3. Market Revenue and Forecast, by Condition Treated
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Program
12.4.5.2. Market Revenue and Forecast, by Therapy
12.4.5.3. Market Revenue and Forecast, by Condition Treated
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Program
12.4.6.2. Market Revenue and Forecast, by Therapy
12.4.6.3. Market Revenue and Forecast, by Condition Treated
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Program
12.4.7.2. Market Revenue and Forecast, by Therapy
12.4.7.3. Market Revenue and Forecast, by Condition Treated
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Program
12.4.8.2. Market Revenue and Forecast, by Therapy
12.4.8.3. Market Revenue and Forecast, by Condition Treated
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Program
12.5.2. Market Revenue and Forecast, by Therapy
12.5.3. Market Revenue and Forecast, by Condition Treated
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Program
12.5.5.2. Market Revenue and Forecast, by Therapy
12.5.5.3. Market Revenue and Forecast, by Condition Treated
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Program
12.5.6.2. Market Revenue and Forecast, by Therapy
12.5.6.3. Market Revenue and Forecast, by Condition Treated
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Select Medical Holdings
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Encompass Health
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Kindred Healthcare
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ATI Physical Therapy
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Shirley Ryan AbilityLab
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. LHC Group
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Mayo Clinic
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Brooks Rehabilitation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Kessler Institute for Rehabilitation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. U.S. Physical Therapy Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
